Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Topical cyclosporin in oral lichen planus: A controlled, randomized, prospective trial

P. Sieg*, H. Von Domarus, V. Von Zitzewitz, H. Iven, L. Farber

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

The published studies of topical cyclosporin (CyA) therapy in chronic oral lichen planus (OLP) have shown conflicting results. We report an investigator-blinded study of 13 patients with OLP, who were randomly assigned to treatment with CyA (500 mg as a swish-and-spit medication for 5 min three times daily) or a corticosteroid oral paste (triamcinolone acetonide). The duration of treatment was 6 weeks. Thereafter, patients on corticosteroid therapy were treated with CyA, Only slight, transient clinical improvement was observed in both groups after 6 weeks of treatment, compared with baseline. No significant differences could be demonstrated between the two groups. CyA therapy following corticosteroid treatment did not produce any further clinical improvement. During follow-up of the disease for up to 1 year after treatment, neither the CyA nor the corticosteroid group exhibited long-term improvement in disease activity. Contradictory results from earlier reports are discussed.

OriginalspracheEnglisch
ZeitschriftBritish Journal of Dermatology
Jahrgang132
Ausgabenummer5
Seiten (von - bis)790-794
Seitenumfang5
ISSN0007-0963
DOIs
PublikationsstatusVeröffentlicht - 1995

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Fingerprint

Untersuchen Sie die Forschungsthemen von „Topical cyclosporin in oral lichen planus: A controlled, randomized, prospective trial“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren